CancerGuiding age-specific recommendations for pediatric cancers
UC Davis Comprehensive Cancer Center epidemiologists led a novel analysis of more than 1 million U.S. cancer patients last year, and found that second cancers in children and in adolescents and young adults (AYA) are far deadlier than they are in older adults – and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall. Their study in JAMA Oncology also found that survival after almost all types of cancer is much higher when the cancer is a primary malignancy, and that survival differences are most pronounced in patients under age 40.
Our researchers hope the findings will help guide clinicians in providing age-specific recommendations on prevention, screening, treatment and survivorship – especially among the AYA population, whose survival rates have not improved to the same extent as for children and older adults.
